Solabia completes Mibelle Biochemistry acquisition
Key takeaways
- Solabia strengthens its biotech leadership in beauty and wellness through the acquisition of Mibelle Biochemistry.
- Combining Solabia’s global reach with Mibelle’s plant stem cell and biotech expertise accelerates the development of differentiated cosmetic and nutraceutical solutions.
- The acquisition enhances offerings in skin beauty, healthy aging, hair care, and cognitive support, backed by science-driven, sustainable innovation.
Solabia Group has completed its acquisition of Mibelle Biochemistry, the Swiss specialist in science-backed active ingredients for the cosmetics and nutraceutical industries. The deal, from Persán, was initially announced in February 2026.
The closing is touted as “an important step in Solabia’s growth strategy, strengthening its position as a key leader in biotechnology-driven, natural and high-performance active ingredients.”
A new chapter
According to Jean‑Baptiste Dellon, CEO of Solabia, the completion opens a “new chapter” for Solabia and Mibelle Biochemistry.
“Our teams share the same commitment to scientific excellence, sustainable innovation, and customer proximity. Together, we are now even better positioned to support our customers with a broader, stronger, and highly complementary range of ingredients.”
By combining Solabia’s international footprint and industrial expertise with Mibelle Biochemistry’s recognized innovation capabilities, the group will further expand its portfolio and accelerate the development of differentiated solutions for beauty and well-being markets.
Meanwhile, Cornelia Schürch, head of Mibelle Biochemistry, adds: “Joining Solabia gives Mibelle Biochemistry the opportunity to build on its strong scientific heritage while opening new perspectives for international development. We’re excited to combine our expertise and continue delivering innovative, high-quality ingredients to our customers worldwide.”
Personal Care Insights recently caught up with Mibelle’s founder, Fred Zülli, at NYSCC Suppliers’ Day. We spoke to him about how the Solabia acquisition will shape the company’s R&D and strategy.
Harnessing modern technology for personal care
Mibelle Biochemistry will expand its portfolio and accelerate the development of differentiated solutions for beauty and well-being.Founded in Switzerland in 1991, Mibelle Biochemistry is known for its work in plant stem cell technology and modern biotechnology, with a portfolio covering skin beauty, healthy aging, hair care, and cognitive support. Its actives are distributed in over 50 global countries.
Last month, the company released a “breakthrough” approach to calcium delivery in skin care, EpiCalsome. Mibelle says that electrolytes such as calcium, magnesium, potassium, and sodium are emerging as key ingredients in modern skin care.
Additionally, at In-Cosmetics Global 2026, Mibelle Biochemistry introduced longevity-focused ingredients for skin and hair care. Franziska Wandrey, head of research, told us about how EpiSnow, an active ingredient designed to target the skin’s biological aging clock, tackles seven hallmarks of aging. The company also expanded into hair longevity with PhytoSpherix Hair, a plant-based ingredient that delivered glycogen to hair follicles to boost energy and support growth. While most glycogen sources are animal-derived, the alternative was sourced from sweet corn.
